F2 and cancer: We demonstrate the superior antiproliferativeactivity of the new Pt(IV) complexes containing DCF axial ligand(s)against a panel of cancer cell lines of various origins, particularlyin the case of Pt(IV) complex 4 (containing two axialDCF ligands), which achieved comparable or even better activity thanthe parental Pt(II) complex 1.